Posted on 12/23/20
Kala Pharmaceuticals Should Have Limited Downside With Eysuvis Now Approved
Summary Kala Pharmaceuticals got its second ocular therapy, Eysuvis, approved on October 27.Peak sales estimates range from $500 million to over $1 billion due to its . . .
Posted on 12/23/20
Why Did Moderna Stock Fall on Good News Last Week?
Last week was a very good one for Moderna's (NASDAQ:MRNA) COVID-19 vaccine mRNA-1273. An advisory committee to the U.S. Food and Drug Administration (FDA) unanimously voted . . .
Posted on 12/23/20
Vertex Pharmaceuticals Enters New Partnership With RNA Expert Skyhawk Therapeutics
Vertex Pharmaceuticals (NASDAQ:VRTX) announced on Tuesday morning that it's entering a new partnership with a privately held Skyhawk Therapeutics, a biotech focused on discovering small-molecule drugs . . .
Posted on 12/22/20
Azara Healthcare and SPH Analytics’ Population Health Division Announce Merger
BOSTON--(BUSINESS WIRE)--Azara Healthcare, a leading provider of population health solutions to the community health market, and SPH Analytics, a leader in healthcare consumer experience measurement, engagement . . .
Posted on 12/22/20
Coagulo Medical Technologies Announces $6.5 Million in Financing
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Coagulo Medical Technologies, an MIT-born startup that has developed the world’s first precision-medicine platform for comprehensive and targeted blood clotting management, today announced it . . .
Posted on 12/22/20
Gamida Cell Closes $75M Public Offering
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced that its previously . . .
Posted on 12/21/20
CVS Health Cash Tender Offers to an Aggregate Principal Amount of $4,500,000,000 from $4,000,000,000 of Certain Outstanding Notes
CVS Health Corporation announced today the early results of the previously announced cash tender offers and that it is amending the Tender Offers by increasing the . . .
Posted on 12/21/20
Servier to Acquire Agios Pharmaceuticals Oncology Business
Servier, a global pharmaceutical company, today announced that it has entered into an agreement for the acquisition of Agios Pharmaceuticals' oncology business including its commercial, clinical . . .
Posted on 12/21/20
Life Science Marketing Agency on Track for Record Year
Boston pharmaceutical marketing agency, ramarketing, will grow over 75pc this year due to surging global demand for the company’s industry expertise in drug development and manufacturing.The . . .
Posted on 12/21/20
Keros Therapeutics Announces Addition to NASDAQ Biotechnology Index
LEXINGTON, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments . . .
Posted on 12/21/20
Aileron Therapeutics Provides Business Update
WATERTOWN, Mass., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN) today provided a business update and outlined its strategic priorities for 2021, including announcing more . . .
Posted on 12/21/20
EyeGate Pharma Acquires Panoptes Pharma
EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), a clinical stage company focused on developing products for treating disorders of the eye, today announced the acquisition of Panoptes Pharma
Posted on 12/21/20
CVS: Crushing The Market One Stock At A Time
Summary CVS exhibits a consumer defensive business with strong competitive advantages.CVS is in great financial shape, growth prospects remain encouraging, and the stock is significantly undervalued.CVS . . .
Posted on 12/21/20
Where Will Biogen Be in 5 Years?
Biogen (NASDAQ:BIIB) is a large-cap biotech that has witnessed significant volatility this year, with over 40% price swings in both directions. As it turns out, market . . .
Posted on 12/21/20
Does Pfizer's Vaccine Authorization Improve Moderna's Chances?
Pfizer(NYSE:PFE) received U.S. Emergency Use Authorization (EUA) for its COVID-19 vaccine on Dec. 11, 2020. This has raised hopes that Moderna(NASDAQ:MRNA) could soon win EUA for . . .
Posted on 12/21/20
Will Moderna Stock Hit $200 in 2021?
Moderna (NASDAQ:MRNA) has been one of the leaders in the race to develop a coronavirus vaccine, and as a result, its shares have soared by more . . .
Posted on 12/21/20
Moderna to Provide 80 Million Additional Doses of Coronavirus Vaccine to European Authorities
Once again, a recipient of Moderna's (NASDAQ:MRNA) mRNA-1273 coronavirus vaccine candidate is exercising its option for more doses. On Friday, the company announced that the European . . .
Posted on 12/21/20
Moderna Gains FDA Authorization for Its Coronavirus Vaccine
The Food and Drug Administration authorized a second coronavirus vaccine on Friday. The emergency use authorization (EUA) for Moderna's (NASDAQ:MRNA) mRNA-1273 comes just a day after . . .
Posted on 12/18/20
Sensible Medical Brings the Portable JADE Commercial Grade Air Purification System to Hospitals, Clinics and Offices Across the U.S.
Sensible Medical, a Hanover, MA distributor of medical grade air purification systems for hospitals, clinics and offices announces that it is the authorized USA distributor for . . .
Posted on 12/18/20
TPG and TA Associates Close on $1.6 Billion Planview Acquisition from Thoma Bravo
AUSTIN, Texas & SAN FRANCISCO & FORT WORTH, Texas & BOSTON--(BUSINESS WIRE)--TPG Capital, the private equity platform of global alternative asset firm TPG, and TA Associates, . . .
Posted on 12/18/20
Will Moderna Stock Soar If Its COVID Vaccine Is Authorized?
Pfizer's (NYSE:PFE) share price actually fell a little after an advisory committee to the U.S. Food and Drug Administration (FDA) recommended Emergency Use Authorization (EUA) for . . .
Posted on 12/18/20
FDA Advisers Vote Unanimously Recommending Authorization of Moderna's Coronavirus Vaccine
After a full day of discussions, the Food and Drug Administration (FDA) advisory committee voted unanimously to recommend authorization of mRNA-1273, Moderna's (NASDAQ:MRNA) coronavirus vaccine. There . . .
Posted on 12/17/20
Gamida Cell Prices of $65 Million Public Offering of Ordinary Shares
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced the pricing of . . .
Posted on 12/17/20
Cadent Therapeutics to be Acquired by Novartis
Cadent Therapeutics, a privately held clinical stage biopharmaceutical company focused on the development of therapies for the treatment of cognitive, mood, and movement disorders,
Posted on 12/17/20
Gamida Cell Launch of Public Offering of Ordinary Shares
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced the launch of . . .
Boston
